Cardinal Health's ROE % for the quarter that ended in Mar. 2026 was Negative Equity. Cardinal Health's PB Ratio for the quarter that ended in Mar. 2026 was N/A.
Cardinal Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was Negative Equity.
Cardinal Health ROE % Adjusted to Book Value Related Terms
Cardinal Health ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Cardinal Health's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardinal Health ROE % Adjusted to Book Value Chart
FRA:CLH vs COR, MCK, HSIC: ROE % Adjusted to Book Value Comparison
For the Medical Distribution subindustry, Cardinal Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardinal Health ROE % Adjusted to Book Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cardinal Health's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Cardinal Health's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of Negative Equity% mean?
Cardinal Health (FRA:CLH) has a ROE % Adjusted to Book Value of Negative Equity% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Cardinal Health and its competitors.
Is Cardinal Health's ROE % Adjusted to Book Value too high?
Cardinal Health's current ROE % Adjusted to Book Value is Negative Equity%. Overall, Cardinal Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardinal Health's ROE % Adjusted to Book Value compare to COR and MCK?
Cardinal Health's ROE % Adjusted to Book Value of Negative Equity% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Distribution company?
A good ROE % Adjusted to Book Value depends on the Medical Distribution industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Cardinal Health and its competitors. Cardinal Health's current ROE % Adjusted to Book Value is Negative Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardinal Health stock overvalued right now?
Based on GuruFocus' analysis, Cardinal Health (FRA:CLH) is currently considered Significantly Overvalued. The stock's GF Value™ is €120.72, compared to a current price of €209.10 — trading 73.2% above its estimated fair value. The current ROE % Adjusted to Book Value is Negative Equity%. Cardinal Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Cardinal Health (FRA:CLH), the current ROE % Adjusted to Book Value is Negative Equity% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardinal Health (FRA:CLH) Overvalued in 2026?
Based on GuruFocus' analysis, Cardinal Health stock appears to be overvalued.
The current stock price of €209.10 is trading 73.2% above its estimated GF Value™ of €120.72.
GuruFocus considers Cardinal Health to be Significantly Overvalued.
Key valuation signals for FRA:CLH:
ROE % Adjusted to Book Value: Negative Equity%
GF Value™: €120.72 vs. price of €209.10 (73.2% above fair value)
No single metric tells the full story. See the FRA:CLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
81GF Score
Get the complete analysis for FRA:CLH
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CLH has been successfully added to your 
